SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-002779
Filing Date
2017-02-03
Accepted
2017-02-03 19:44:13
Documents
2
Period of Report
2017-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3132
2 EX-24 DOCUMENT attachment1.htm EX-24 3587
  Complete submission text file 0000899243-17-002779.txt   8173
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O PROTINE DESIGN LAB 37481 MARSTEN DR NEWARK CA 94560
Business Address
SHAH JAISIM (Reporting) CIK: 0001242133 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 17573767